Misleading hyperprolactinaemia in pregnancy

Lancet

Volumn 353, Issue 9154, 1999, Pages 720-

  Heaney, A P ^a   Laing, I ^a   Walton, L ^a   Seif, M W ^a   Beardwell, C G ^a   Davis, J R E ^a,b  

^a WITHINGTON HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FEMALE INFERTILITY; HEADACHE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; SIDE EFFECT;

EID: 0033608380     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(98)10183-6     Document Type: Article

References (5)

1. Olukoga AO, Kane J. Anti-prolactin antibodies and hyperprolactinaemia. Eur J Endocrinol 1995; 133: 463-64.
2. Miyai K, Ichihara K, Kondo K, Mori S. Asymptomatic hyperprolactinaemia and prolactinoma in the general population - mass screening paired assays of serum prolactin. Clin Endocrinol 1986; 25: 549-54.
3. Suh HK, Frntz AG. Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 1974; 39: 928-35.
4. Bjoro T, Morkid L, Wergeland R, et al. Frequency of hyperprolactinaemia due to large molecular weight prolactin (150-170 kD PRL). Scand J Clin Lab Invest 1995; 55: 139-47.
5. Jackson RD, Wortsman J, Malarkey WB. Persistence of large molecular weight prolactin secretion during pregnancy in women with macroprolactinaemia and its presence in fetal cord blood. J Clin Endocrinol Metab 1989; 68: 1046-50.